These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 11279642)
1. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642 [TBL] [Abstract][Full Text] [Related]
2. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa. Majumdar G; Phillips JK; Lavallee H; Savidge GF Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477 [TBL] [Abstract][Full Text] [Related]
3. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Federici AB; Stabile F; Castaman G; Canciani MT; Mannucci PM Blood; 1998 Oct; 92(8):2707-11. PubMed ID: 9763553 [TBL] [Abstract][Full Text] [Related]
4. [Acquired von Willebrand syndrome]. de Lange DW; Fijnheer R; Wittebol S Ned Tijdschr Geneeskd; 2003 Sep; 147(37):1808-11. PubMed ID: 14526622 [TBL] [Abstract][Full Text] [Related]
5. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Sucker C; Michiels JJ; Zotz RB Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364 [TBL] [Abstract][Full Text] [Related]
6. [Acquired von Willebrand syndrome: from diagnosis to treatment]. Bustany S; Gautier P; Lequerrec A; Troussard X; Ollivier Y; Borel-Derlon A Pathol Biol (Paris); 2009; 57(7-8):536-42. PubMed ID: 19193498 [TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand's syndrome: a single institution experience. Kumar S; Pruthi RK; Nichols WL Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134 [TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [TBL] [Abstract][Full Text] [Related]
9. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor. Grossmann RE; Geisen U; Schwender S; Keller F Thromb Haemost; 2000 Apr; 83(4):633-4. PubMed ID: 10780333 [No Abstract] [Full Text] [Related]
11. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712 [TBL] [Abstract][Full Text] [Related]
12. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate. Berntorp E; Windyga J; Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options. Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130 [TBL] [Abstract][Full Text] [Related]
14. [Perioperative management of a patient with an acquired von Willebrand syndrome]. Clapson P; Bordier E; Grasser L; Merat S; Diraison Y; Brinquin L Ann Fr Anesth Reanim; 2008 Jan; 27(1):86-9. PubMed ID: 18155390 [TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM; Easley RB; Tobias JD Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome. Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672 [TBL] [Abstract][Full Text] [Related]
17. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome. Macik BG; Gabriel DA; White GC; High K; Roberts H Arch Pathol Lab Med; 1988 Feb; 112(2):143-6. PubMed ID: 2447856 [TBL] [Abstract][Full Text] [Related]
18. Association of acquired von Willebrand syndrome with AL amyloidosis. Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535 [TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. Frank RD; Kunz D; Wirtz DC Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985 [TBL] [Abstract][Full Text] [Related]
20. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]